-
Mashup Score: 0The Artera AI Model: Advancing Personalized Medicine in Prostate Cancer Treatment | Dan Spratt & Alicia Morgans Discuss NEJM Evidence Manuscript - 10 month(s) ago
Dan Spratt joins Alicia Morgans in a conversation on the Artera AI multimodal artificial intelligence model manuscript published in the NEJM Evidence. The Artera predictive model for prostate cancer is a significant advancement in personalized medicine for patients with localized prostate cancer. Unlike prognostic biomarkers that help identify patients at lower or higher risk of developing…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Immune Checkpoint B7-H3 is a Therapeutic Vulnerability in Prostate Cancer Harboring PTEN and TP53 Deficiencies - Di Zhao - 10 month(s) ago
Andrea Miyahira invites Di Zhao to discuss her research published in Science Translational Medicine entitled “Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies.” Dr. Zhao’s team explored immune checkpoint B7-H3, identified as a promising target for advanced prostate cancer with PTEN and p53 deficiencies. Their analysis of immune…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Exciting insights into #ProstateCancer therapy! 🙌 @Dr_Di_Zhao joins @AndreaMiyahira to discuss the therapeutic vulnerability of immune checkpoint B7-H3 in #PCa with PTEN and TP53 deficiencies. Potential breakthroughs in treating adv prostate cancer > https://t.co/P68sWdGTjt https://t.co/W4dniMuMcK
-
-
Mashup Score: 0Harnessing Exercise to Improve Outcomes in Black Prostate Cancer Patients - Dong-Woo (Derek) Kang - 10 month(s) ago
Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Harnessing exercise to improve outcomes in Black #ProstateCancer patients. @DKang_PhD @DanaFarber joins @CaPsurvivorship to discuss an ongoing #exercise study focused on Black patients with #PCa undergoing androgen deprivation therapy #ADT > https://t.co/ubWu5CBcqU https://t.co/hrMaAJtxSQ
-
-
Mashup Score: 9Prostate Cancer Disparities: Addressing Inequities and Empowering Change - Kelvin Moses - 10 month(s) ago
Zach Klaassen and Kelvin Moses discuss prostate cancer disparities in 2023. Dr. Moses highlights the disparities black men face in prostate cancer, including lower screening rates, higher grades or stages of disease, and a higher risk of death compared to white men. Dr. Moses mentions his involvement in the Southern Community Cohort Study (SCCS), focusing on screening patterns for prostate…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#ProstateCancer disparities: Addressing inequities and empowering change. Kelvin Moses, MD @VUMCurology joins @zklaassen_md to discuss disparities Black men face in #PCa and the importance of education, community outreach, & addressing implicit biases > https://t.co/TxXKdz4HYF https://t.co/ksDVrPzKFE
-
-
Mashup Score: 0The Artera AI Model: Advancing Personalized Medicine in Prostate Cancer Treatment | Dan Spratt & Alicia Morgans Discuss NEJM Evidence Manuscript - 10 month(s) ago
Dan Spratt joins Alicia Morgans in a conversation on the Artera AI multimodal artificial intelligence model manuscript published in the NEJM Evidence. The Artera predictive model for prostate cancer is a significant advancement in personalized medicine for patients with localized prostate cancer. Unlike prognostic biomarkers that help identify patients at lower or higher risk of developing…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The @arteraAI model: Advancing personalized #medicine in #ProstateCancer treatment. #WatchNow @DrSpratticus @caseccc & @CaPsurvivorship @DanaFarber discuss the @NEJMEvidence manuscript and the #Artera predictive model for #PCa on UroToday > https://t.co/566DsSv8v4 https://t.co/dLlfS5EyFk
-
-
Mashup Score: 0Advances in Advanced Prostate Cancer - Silke Gillessen - 11 month(s) ago
In this conversation between Alicia Morgans and Professor Silke Gillessen, they discuss the advances and controversies in advanced prostate cancer. They talk about the changing landscape of treatment options, triplet therapy, and highlight several GU ASCO 2023 meeting presentations. This includes the overall survival data from the PROpel trial, which tested the combination of abiraterone and…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Exciting developments in advanced #PCa treatment! Join @CaPsurvivorship @DanaFarber and @Silke_Gillessen @IOR_Bellinzona as they discuss the latest advancements in treatment options, the importance of biomarkers, genetic testing, and radioligands > https://t.co/6t1lUe0s3H https://t.co/Jr10LOMVuT
-
-
Mashup Score: 0The Artera AI Model: Advancing Personalized Medicine in Prostate Cancer Treatment | Dan Spratt & Alicia Morgans Discuss NEJM Evidence Manuscript - 11 month(s) ago
Dan Spratt joins Alicia Morgans in a conversation on the Artera AI multimodal artificial intelligence model manuscript published in the NEJM Evidence. The Artera predictive model for prostate cancer is a significant advancement in personalized medicine for patients with localized prostate cancer. Unlike prognostic biomarkers that help identify patients at lower or higher risk of developing…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
The @arteraAI model: Advancing personalized #medicine in #ProstateCancer treatment. #WatchNow @DrSpratticus @caseccc & @CaPsurvivorship @DanaFarber discuss the @NEJMEvidence manuscript and the #Artera predictive model for #PCa on UroToday > https://t.co/566DsSv8v4 https://t.co/OetfRcKqcP
-
-
Mashup Score: 0Prostate Cancer Disparities: Addressing Inequities and Empowering Change - Kelvin Moses - 11 month(s) ago
Zach Klaassen and Kelvin Moses discuss prostate cancer disparities in 2023. Dr. Moses highlights the disparities black men face in prostate cancer, including lower screening rates, higher grades or stages of disease, and a higher risk of death compared to white men. Dr. Moses mentions his involvement in the Southern Community Cohort Study (SCCS), focusing on screening patterns for prostate…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
#ProstateCancer disparities: Addressing inequities and empowering change. Kelvin Moses, MD @VUMCurology joins @zklaassen_md to discuss disparities Black men face in #PCa and the importance of education, community outreach, & addressing implicit biases > https://t.co/TxXKdz5fOd https://t.co/roHBE5qYxx
-
-
Mashup Score: 0Harnessing Exercise to Improve Outcomes in Black Prostate Cancer Patients - Dong-Woo (Derek) Kang - 11 month(s) ago
Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Harnessing exercise to improve outcomes in Black #ProstateCancer patients. @DKang_PhD @DanaFarber joins @CaPsurvivorship to discuss an ongoing #exercise study focused on Black patients with #PCa undergoing androgen deprivation therapy #ADT > https://t.co/ubWu5CBcqU https://t.co/kkUAcHWKrz
-
-
Mashup Score: 5The Importance of a Prostate Cancer Survivorship Program: A Multi-Disciplinary Approach - 11 month(s) ago
prostate cancer, radiation therapy, radical prostatectomy, focal therapy, androgen deprivation therapy, chemotherapy, novel hormonal therapy, immunotherapy, Urinary Dysfunction, ProtecT trial, sexual dysfunction, Bowel dysfunction, rectal toxicity, spaceOAR, BioProtect.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The importance of a #ProstateCancer #survivorship program: a multi-disciplinary approach. #LibraryResource @zklaassen_md @GACancerCenter and @kingurology @mcg_urology discuss physical and psychological side effects of #PCa diagnosis & treatment > https://t.co/1Rv4sdKWhb https://t.co/3qwey901j9
-
The @arteraAI model: Advancing personalized #medicine in #ProstateCancer treatment. #WatchNow @DrSpratticus @caseccc & @CaPsurvivorship @DanaFarber discuss the @NEJMEvidence manuscript and the #Artera predictive model for #PCa on UroToday > https://t.co/566DsSv8v4 https://t.co/ZmHKhzHPBg